ACONW
Aclarion IncNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-6.58
Beta
1.14
52W High
$0.10
52W Low
$0.02
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Aclarion Inc
Aclarion Inc is a pioneering healthcare technology firm focused on revolutionizing the diagnosis and treatment of musculoskeletal disorders through non-invasive imaging solutions. By leveraging advanced data analytics and proprietary algorithms, the company seamlessly integrates imaging with clinical data to provide actionable insights that support personalized medicine. Aclarion is well-positioned to address the dynamic needs of the medical community, enhancing patient outcomes and streamlining clinical workflows. With a commitment to expanding its market presence, Aclarion is at the forefront of transforming healthcare diagnostics, catering to both patients and providers who seek efficient and innovative solutions.
Fundamentals
| Revenue (TTM) | 75,730 |
| Gross Profit (TTM) | 6,830 |
| EBITDA | $-6.82M |
| Operating Margin | -10785.00% |
| Return on Equity | -104.80% |
| Return on Assets | -55.80% |
| Revenue/Share (TTM) | $0.14 |
| Book Value | $15.02 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 80.60% |
| Shares Outstanding | 0 |
| Float | $2.04M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/7/2026